abstract |
The invention provides FGFR1 (Fibroblast Growth Factor Receptor1) non-ATP (Adenosine Triphosphate) competitive inhibitor acrylamide compounds. Besides, the invention also provides a medicine composite of the compounds, anti-tumor application of the compounds, and the like. |